← Browse by Condition
Medical Condition

aging healthy

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2

Clinical trials often recruit healthy volunteers for Phase 1 pharmacokinetic and safety studies, vaccine immunogenicity assessments, and normal physiological reference studies. These trials are essential for establishing safe dose ranges and understanding how drugs behave in the absence of disease before testing in patient populations.

Healthy volunteer studies include first-in-human drug trials, vaccine efficacy (flu, RSV, COVID-19, malaria), microbiome intervention studies, exercise physiology research, and device safety assessments. Compensation is often provided; eligibility typically requires no significant medical history and a negative drug screen.

Healthy volunteer trials require participants to be in good general health with no significant medications. Many exclude smokers, pregnant individuals, and those with recent prior trial participation.

Trial Phases
Phase 2
1
Top Sponsors
YOXLO B.V. 1 trial
David Marcinek 1 trial

Recruiting Clinical Trials

NCT07442097
Recruiting

Safe-Age Study: A Safety and Tolerability Study of a Nutritional Supplement in Healthy Older Adults

Enrollment
16 pts
Location
India
Sponsor
YOXLO B.V.
View Trial →
NCT07275424 Phase 2
Recruiting

Study of Healthy Aging and Physical Function With Elamipretide

Enrollment
30 pts
Location
United States
Sponsor
David Marcinek
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology